ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
Mutations in the BAF SWI/SNF complex subunits are frequent in cancers but selective therapeutic approaches are not available yet. Here, the authors demonstrate that defects ofARID1Aand other subunits sensitizes cancer cells to the DNA checkpoint kinase inhibitor ATR in a synthetic lethal manner.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e641244f3cf24d9e87d1e6540b5b48bf |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|